Studies have reported that in malignant tumors such as gastric cancer [13], colon cancer [18], pancreatic cancer [26], osteosarcoma [25], and ESCC [19], the expression of NOX2 in tumor tissues is higher than that in adjacent non-cancerous tissues. This evidence concerns the gene CYBB and familial pancreatic carcinoma.